rgupta
Regular
There are a lot of areas beyond anyone control and SP is one of them. Technically we share holders own the company and we are free to buy or sell shares of any company. But we don't change management every day and reason being management is responsible for all the decisions.On Tuesday I hope to join other shareholders and attend the AGM of BRN as I did last year.
In the intervening 12 months the market value of our BRN investments has declined $0.68c from $1.15 to 47c per share., a drop of 60%.
To get back to where we were 12 month ago, the current share price will have to bounce by 150%, a considerable ask. A rise of over 300% would be needed to take us back to the heights of early 2022.
If I had sold 1000 shares ago 12 months ago for $1150, I could have brought back 2446 shares at Fridays closing price. When this parcel of shares recovers to last years AGM price it would have a market value of $$2812, The gain/loss of $1662 for the sale of 1000 shares represents the opportunity cost of holding on to my shares and not trading them.
Unlike what is often suggested on this forum, the responsibility for this decline in portfolio value is mine, not the Companies. I was not clever enough to trade my shares. I chose not to take the advice of “down rampers” or the much maligned shorter”. I read TSE and comfort my self that I am an investor, not a share trader, but that has come at a financial cost.
So what do I expect at the AGM?
I would like to hear a clear roadmap of how the company plans to execute and achieve commercialisation.
I do not believe it is sufficient for the company to simply repeat their confident assertion made (unchanged) in the last two quarterly updates, namely:
“in the coming (months) the Company will focus on key sales targets and converting technical evaluations into paid licences. In addition, the Company is accelerating development of next-generation Akida IP and products to extend our technological lead and market opportunity. We remain positive on future market penetration and broad adoption of BrainChip’s technology”.
It would be an insult to “loyal shareholders” to offer no further information or comfort than this to long term shareholders.
We need to understand why paid licences and IP fees have not materialised in the promised way.
We need some comfort that partners/enablers/facilitators are going to part out some hard cash shortly. Or does Akida merely remain the enthusiastic plaything of researchers and technophiles and is not a commercial proposition.
Sure there have been economic headwinds, and Akida technology is revolutionary. However “sales will explode” and “watch the financials” have a hollow ring at the moment.
In the past the Board and Management have shown a commendable willingness and ability to shift strategy and respond to the needs of Akida customers. However the responsibility of the Board and Management is to put in place and execute a successful strategy to bring Akida to the market and to achieve sales.
Hopefully we will be surprised at the AGM.
I am looking forward to receiving from the Board and Management a clear explanation, more information and a executable plan of how commercialisation is to be achieved and delivered to the patient/committed investor shareholders, or are we to remain the plaything of traders?
As always, just my opinion.
OutbackJohn
Management take its decision based on best interest of company and best interest is based on long term share holder interest. Company and management were not responsible when share goes up to 2.38 and they are not responsible when it comes down to 35 cents.
Market make its own choices.
I am not finding any broken promise from management and that means cannot make management responsible for present SP.
Dyor